NICE Clears Cosentyx For Psoriasis And Moventig For Constipation
Final draft guidance recommends Novartis’s IL-17 inhibitor for use in Britain’s National Health Service if supplied at a discounted price, and AstraZeneca’s peglyated naloxol product.
Final draft guidance recommends Novartis’s IL-17 inhibitor for use in Britain’s National Health Service if supplied at a discounted price, and AstraZeneca’s peglyated naloxol product.